These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 27956387)

  • 1. Targeting sphingosine kinase 1 induces MCL1-dependent cell death in acute myeloid leukemia.
    Powell JA; Lewis AC; Zhu W; Toubia J; Pitman MR; Wallington-Beddoe CT; Moretti PA; Iarossi D; Samaraweera SE; Cummings N; Ramshaw HS; Thomas D; Wei AH; Lopez AF; D'Andrea RJ; Lewis ID; Pitson SM
    Blood; 2017 Feb; 129(6):771-782. PubMed ID: 27956387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant targeting of FLT3 and SPHK1 exerts synergistic cytotoxicity in FLT3-ITD
    Jiang L; Zhao Y; Liu F; Huang Y; Zhang Y; Yuan B; Cheng J; Yan P; Ni J; Jiang Y; Wu Q; Jiang X
    Cell Commun Signal; 2024 Aug; 22(1):391. PubMed ID: 39113090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent targeting Akt and sphingosine kinase 1 by A-674563 in acute myeloid leukemia cells.
    Xu L; Zhang Y; Gao M; Wang G; Fu Y
    Biochem Biophys Res Commun; 2016 Apr; 472(4):662-8. PubMed ID: 26920060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple Negative Breast Cancer Depends on Sphingosine Kinase 1 (SphK1)/Sphingosine-1-Phosphate (S1P)/Sphingosine 1-Phosphate Receptor 3 (S1PR3)/Notch Signaling for Metastasis.
    Wang S; Liang Y; Chang W; Hu B; Zhang Y
    Med Sci Monit; 2018 Apr; 24():1912-1923. PubMed ID: 29605826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SphK1 inhibitor II (SKI-II) inhibits acute myelogenous leukemia cell growth in vitro and in vivo.
    Yang L; Weng W; Sun ZX; Fu XJ; Ma J; Zhuang WF
    Biochem Biophys Res Commun; 2015 May; 460(4):903-8. PubMed ID: 25824043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATP-binding cassette ABCC1 is involved in the release of sphingosine 1-phosphate from rat uterine leiomyoma ELT3 cells and late pregnant rat myometrium.
    Tanfin Z; Serrano-Sanchez M; Leiber D
    Cell Signal; 2011 Dec; 23(12):1997-2004. PubMed ID: 21803151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acid ceramidase is upregulated in AML and represents a novel therapeutic target.
    Tan SF; Liu X; Fox TE; Barth BM; Sharma A; Turner SD; Awwad A; Dewey A; Doi K; Spitzer B; Shah MV; Morad SA; Desai D; Amin S; Zhu J; Liao J; Yun J; Kester M; Claxton DF; Wang HG; Cabot MC; Schuchman EH; Levine RL; Feith DJ; Loughran TP
    Oncotarget; 2016 Dec; 7(50):83208-83222. PubMed ID: 27825124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of SPHK1 as a therapeutic target and marker of poor prognosis in cholangiocarcinoma.
    Chen MH; Yen CC; Cheng CT; Wu RC; Huang SC; Yu CS; Chung YH; Liu CY; Chang PM; Chao Y; Chen MH; Chen YF; Chiang KC; Yeh TS; Chen TC; Huang CY; Yeh CN
    Oncotarget; 2015 Sep; 6(27):23594-608. PubMed ID: 26090720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of sphingosine-1-phosphate lyase rescues sphingosine kinase-1-knockout phenotype following murine cardiac arrest.
    Gorshkova IA; Wang H; Orbelyan GA; Goya J; Natarajan V; Beiser DG; Vanden Hoek TL; Berdyshev EV
    Life Sci; 2013 Sep; 93(9-11):359-66. PubMed ID: 23892195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of sphingosine kinase-1 reverses the increase in lung vascular permeability through sphingosine-1-phosphate receptor signaling in endothelial cells.
    Tauseef M; Kini V; Knezevic N; Brannan M; Ramchandaran R; Fyrst H; Saba J; Vogel SM; Malik AB; Mehta D
    Circ Res; 2008 Nov; 103(10):1164-72. PubMed ID: 18849324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis.
    Nagahashi M; Ramachandran S; Kim EY; Allegood JC; Rashid OM; Yamada A; Zhao R; Milstien S; Zhou H; Spiegel S; Takabe K
    Cancer Res; 2012 Feb; 72(3):726-35. PubMed ID: 22298596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine kinase-1 inhibition protects primary rat hepatocytes against bile salt-induced apoptosis.
    Karimian G; Buist-Homan M; Schmidt M; Tietge UJ; de Boer JF; Klappe K; Kok JW; Combettes L; Tordjmann T; Faber KN; Moshage H
    Biochim Biophys Acta; 2013 Dec; 1832(12):1922-9. PubMed ID: 23816565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine-1-phosphate promotes expansion of cancer stem cells via S1PR3 by a ligand-independent Notch activation.
    Hirata N; Yamada S; Shoda T; Kurihara M; Sekino Y; Kanda Y
    Nat Commun; 2014 Sep; 5():4806. PubMed ID: 25254944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine kinase inhibitors decrease viability and induce cell death in natural killer-large granular lymphocyte leukemia.
    LeBlanc FR; Liu X; Hengst J; Fox T; Calvert V; Petricoin EF; Yun J; Feith DJ; Loughran TP
    Cancer Biol Ther; 2015; 16(12):1830-40. PubMed ID: 26252351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro-Survival Lipid Sphingosine-1-Phosphate Metabolically Programs T Cells to Limit Anti-tumor Activity.
    Chakraborty P; Vaena SG; Thyagarajan K; Chatterjee S; Al-Khami A; Selvam SP; Nguyen H; Kang I; Wyatt MW; Baliga U; Hedley Z; Ngang RN; Guo B; Beeson GC; Husain S; Paulos CM; Beeson CC; Zilliox MJ; Hill EG; Mehrotra M; Yu XZ; Ogretmen B; Mehrotra S
    Cell Rep; 2019 Aug; 28(7):1879-1893.e7. PubMed ID: 31412253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaempferol mitigates sepsis-induced acute lung injury by modulating the SphK1/S1P/S1PR1/MLC2 signaling pathway to restore the integrity of the pulmonary endothelial cell barrier.
    Gao M; Zhu X; Gao X; Yang H; Li H; Du Y; Gao J; Chen Z; Dong H; Wang B; Zhang L
    Chem Biol Interact; 2024 Aug; 398():111085. PubMed ID: 38823539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia.
    Moujalled DM; Pomilio G; Ghiurau C; Ivey A; Salmon J; Rijal S; Macraild S; Zhang L; Teh TC; Tiong IS; Lan P; Chanrion M; Claperon A; Rocchetti F; Zichi A; Kraus-Berthier L; Wang Y; Halilovic E; Morris E; Colland F; Segal D; Huang D; Roberts AW; Maragno AL; Lessene G; Geneste O; Wei AH
    Leukemia; 2019 Apr; 33(4):905-917. PubMed ID: 30214012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profiling of genes regulated by sphingosine kinase1 signaling in a murine model of hyperoxia induced neonatal bronchopulmonary dysplasia.
    Natarajan V; Ha AW; Dong Y; Reddy NM; Ebenezer DL; Kanteti P; Reddy SP; Usha Raj J; Lei Z; Maienschein-Cline M; Arbieva Z; Harijith A
    BMC Genomics; 2017 Aug; 18(1):664. PubMed ID: 28851267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models.
    Pchejetski D; Doumerc N; Golzio M; Naymark M; Teissié J; Kohama T; Waxman J; Malavaud B; Cuvillier O
    Mol Cancer Ther; 2008 Jul; 7(7):1836-45. PubMed ID: 18644996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingosine 1-phosphate signaling contributes to cardiac inflammation, dysfunction, and remodeling following myocardial infarction.
    Zhang F; Xia Y; Yan W; Zhang H; Zhou F; Zhao S; Wang W; Zhu D; Xin C; Lee Y; Zhang L; He Y; Gao E; Tao L
    Am J Physiol Heart Circ Physiol; 2016 Jan; 310(2):H250-61. PubMed ID: 26589326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.